Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
bioAffinity Technologies, Inc. ( (BIAF) ) has issued an update.
On January 10, 2025, bioAffinity Technologies, Inc. announced that its Compensation Committee approved an amendment to increase the annual base salary of CEO Maria Zannes to $300,000, effective retroactively from November 1, 2024. This adjustment to the CEO’s compensation package reflects ongoing strategic decisions within the company that could have implications for its financial management and stakeholder relations.
More about bioAffinity Technologies, Inc.
YTD Price Performance: -19.79%
Average Trading Volume: 207,866
Technical Sentiment Consensus Rating: Buy
Learn more about BIAF stock on TipRanks’ Stock Analysis page.
